|
1
|
Farah E, El Bizri M, Day R, Matai L, Horne F, Hanna TP, Armstrong D, Marlin S, Jérôme O, Brenner DR, Cheung W, Radvanyi L, Villalba E, Leon N, Cohen C, Chalifour K, Burkes R, Gill S, Berry S, Sheffield BS, Fralick P, Stein BD. Report from the Ready for the Next Round Thought-Leadership Roundtables on Building Resilience in Cancer Care and Control in Canada-Colorectal Cancer Canada; 2021. Curr Oncol 2022; 29:1723-1743. [PMID: 35323343 PMCID: PMC8947543 DOI: 10.3390/curroncol29030143] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Revised: 02/17/2022] [Accepted: 02/18/2022] [Indexed: 12/03/2022] Open
Abstract
(1) Background: The COVID-19 pandemic illuminated vulnerabilities in the Canadian health care system and exposed gaps and challenges across the cancer care continuum. Canada is experiencing significant disruptions to cancer-related services, and the impact these disruptions (delays/deferrals/cancellations) have on the health care system and patients are yet to be determined. Given the potential adverse ramifications, how can Canada’s health care systems build resilience for future threats? (2) Methods: To answer this question, CCC facilitated a series of four thought-leadership roundtables, each representing the views of four different stakeholder groups: patients, physicians, health care system leaders, and researchers. (3) Results: Six themes of strength were identified to serve as a springboard for building resilience including, (1) advancing virtual care and digital health technologies to prevent future interruptions in cancer care delivery. (2) developing real-time data metrics, data sharing, and evidence-based decision-making. (3) enhancing public–private-non-profit partnerships to advance research and strengthen connections across the system. (4) advancing patient-centricity in cancer research to drive and encourage precision medicine approaches to care. (5) investing in training and hiring a robust supply of health care human resources. (6) implementing a national strategy and infrastructure to ensure inter-provincial collaborative data sharing (4). Conclusions: A resilient health care system that can respond to shocks and threats is not an emergency system; it is a robust everyday system that can respond to emergencies.
Collapse
Affiliation(s)
- Eliya Farah
- Colorectal Cancer Canada, Montreal, QC H3G 1J1, Canada; (M.E.B.); (R.D.); (L.M.); (C.C.); (B.D.S.)
- Correspondence: or
| | - Maria El Bizri
- Colorectal Cancer Canada, Montreal, QC H3G 1J1, Canada; (M.E.B.); (R.D.); (L.M.); (C.C.); (B.D.S.)
| | - Radmila Day
- Colorectal Cancer Canada, Montreal, QC H3G 1J1, Canada; (M.E.B.); (R.D.); (L.M.); (C.C.); (B.D.S.)
| | - Lavina Matai
- Colorectal Cancer Canada, Montreal, QC H3G 1J1, Canada; (M.E.B.); (R.D.); (L.M.); (C.C.); (B.D.S.)
| | - Fred Horne
- School of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada;
| | - Timothy P. Hanna
- Department of Oncology, Queen’s University, Kingston, ON K7L 5P9, Canada; (T.P.H.); (S.B.)
- Division of Cancer Care and Epidemiology, Queen’s University, Kingston, ON K7L 5P9, Canada
| | - David Armstrong
- Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, ON L8S 4K1, Canada;
| | - Susan Marlin
- Clinical Trials Ontario, Toronto, ON M5G 1M1, Canada;
| | - Olivier Jérôme
- CATALIS-Clinical Trials Quebec, Montreal, QC H3C 3X6, Canada;
| | - Darren R. Brenner
- Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; (D.R.B.); (W.C.)
- Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Cancer Control Alberta, Calgary, AB T2S 3C3, Canada
| | - Winson Cheung
- Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; (D.R.B.); (W.C.)
| | - Laszlo Radvanyi
- Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada;
| | - Eva Villalba
- Coalition Priorité Cancer au Québec, Saint-Lambert, QC J4P 2J7, Canada;
| | - Natalie Leon
- Jewish General Hospital, Montreal, QC H3T 1E2, Canada;
| | - Chana Cohen
- Colorectal Cancer Canada, Montreal, QC H3G 1J1, Canada; (M.E.B.); (R.D.); (L.M.); (C.C.); (B.D.S.)
| | | | - Ronald Burkes
- Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada;
- Cancer Institute, Princess Margaret Hospital-Ontario, University Health Network, Toronto, ON M5G 1L7, Canada
| | - Sharlene Gill
- BC Cancer, Vancouver, BC V5Z 4E6, Canada;
- Department of Medicine, Division of Medical Oncology, Faculty of Medicine, University of British Columbia, Vancouver, BC V5Z 4E6, Canada
| | - Scott Berry
- Department of Oncology, Queen’s University, Kingston, ON K7L 5P9, Canada; (T.P.H.); (S.B.)
| | - Brandon S. Sheffield
- Division of Advanced Diagnostics, William Osler Health Centre-Brampton Civic Hospital, Brampton, ON L6R 3J7, Canada;
| | - Pamela Fralick
- Innovative Medicines Canada, Ottawa, ON K1P 6L5, Canada;
| | - Barry D. Stein
- Colorectal Cancer Canada, Montreal, QC H3G 1J1, Canada; (M.E.B.); (R.D.); (L.M.); (C.C.); (B.D.S.)
| | | |
Collapse
|